Frankfurt - Delayed Quote EUR
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z.F)
1.5100
+0.0100
+(0.67%)
As of 9:59:02 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Tian (Wenzhi) Chief Executive Officer | Acquisition | Mar 26, 2025 | 85,677,135 |
| Yu (Zhihua) Former | Sale | Nov 13, 2024 | 13,011,440 |
Related Tickers
IMR.MU AC Immune SA
1.7900
+20.62%
IMR.SG AC Immune SA
1.8020
+16.26%
424870.KQ ImmuneOncia
5,710.00
-3.22%
IMR.F AC Immune SA
1.7400
+21.17%
XNCR Xencor, Inc.
9.55
-1.04%
TRVN Trevena, Inc.
1.1500
+9.32%
CMPX Compass Therapeutics, Inc.
2.5550
+2.20%
IMRX Immuneering Corporation
2.1350
+0.23%
NRIX Nurix Therapeutics, Inc.
12.38
-3.13%
KYTX Kyverna Therapeutics, Inc.
3.2500
-4.13%